Cart
sales@molnova.com
cFMS Receptor Inhibitor IV
CAS No. 959626-45-0
cFMS Receptor Inhibitor IV( 5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide )
Catalog No. M28536 CAS No. 959626-45-0
cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 691 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1944 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamecFMS Receptor Inhibitor IV
-
NoteResearch use only, not for human use.
-
Brief DescriptioncFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
-
DescriptioncFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
-
In Vitro——
-
In Vivo——
-
Synonyms5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number959626-45-0
-
Formula Weight378.47
-
Molecular FormulaC22H26N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 31.25 mg/mL (82.57 mM)
-
SMILESN#CC=1OC(=CC1)C(=O)NC2=CC(=CC=C2N3CCCCC3)N4CCCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Plonmarlimab
Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.
-
Emactuzumab
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.
-
Mavrilimumab
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling.
